# Medical & Surgical Hospitals × Product & R&D Playbook

## Overview

Medical & Surgical Hospitals' Product & R&D departments face unprecedented pressure to accelerate innovation cycles while maintaining rigorous compliance standards. From managing complex clinical trial protocols and IRB submissions to coordinating FDA 510(k) clearances and breakthrough device designations, R&D teams are drowning in administrative overhead that pulls resources away from actual innovation. Traditional project management tools force teams to manually track hundreds of regulatory milestones, research protocols, and cross-functional dependencies across biomedical engineering, clinical research, and regulatory affairs.

monday.com's AI Work Platform transforms this paradigm by deploying intelligent agents that handle the heavy lifting of regulatory compliance, protocol management, and cross-departmental coordination. Instead of hiring additional project managers and regulatory specialists, our AI agents work 24/7 to monitor FDA guidance updates, automatically generate compliance documentation, and proactively escalate critical pathway delays. This enables Product & R&D leaders to redirect human capital toward breakthrough medical device innovation, accelerate time-to-market for life-saving technologies, and scale their innovation pipeline without exponentially growing administrative overhead.

## Value Driver Mapping

| Value Driver | Application in Medical R&D | Typical Impact |
|--------------|---------------------------|----------------|
| **Replace/Augment Headcount** | AI agents manage regulatory compliance tracking, clinical trial coordination, and protocol adherence monitoring 24/7 | Eliminate 2-3 regulatory coordinator roles, reduce clinical research associate workload by 40% |
| **Consolidate Tech Stack** | Replace disparate systems (CTMS, eTMF, regulatory databases, project tools) with unified AI platform | Reduce vendor spend by 60%, eliminate data silos between preclinical and clinical teams |
| **Scale Without Overhead** | Launch multiple device development programs simultaneously without proportional staff increases | 3x pipeline capacity with same headcount, accelerate commercialization timelines by 25% |

## Prioritized Use Cases

### 1. FDA Regulatory Pathway Intelligence Agent

**Relevance:** Critical - All medical devices require FDA clearance/approval
**Value Driver:** Replace/Augment Headcount + Consolidate Tech Stack
**The Pain:** Regulatory teams manually track changing FDA guidance, submission requirements, and predicate device analyses. Each 510(k) submission requires 200+ hours of regulatory intelligence gathering and documentation preparation.
**The Solution:** AI agent continuously monitors FDA databases, analyzes regulatory pathways, auto-generates submission templates, and provides real-time guidance on optimal regulatory strategies.
**The Outcome:** Reduce 510(k) preparation time by 50%, eliminate regulatory surprises, accelerate time-to-submission by 3-4 months.
**Discovery Questions:**
- How many medical devices are you developing simultaneously?
- What's your average time from design freeze to FDA submission?
- How many regulatory specialists are dedicating time to pathway research?
- What percentage of your submissions receive FDA questions requiring additional information?

**Industry Context:** With FDA's increasing focus on digital health technologies and the Medical Device User Fee Amendments (MDUFA), regulatory pathways are becoming more complex and dynamic.

**VIBE PROMPT:** "Create a medical device regulatory tracking system with columns for Device Name (text), FDA Classification (dropdown: Class I/II/III), Regulatory Pathway (dropdown: 510(k)/PMA/De Novo), Predicate Devices (long text), Submission Deadline (date), FDA Response Date (date), Regulatory Risk Level (status: Low/Medium/High), and Compliance Checklist (checklist with items like 'Quality System Regulation', 'Clinical Data Package', 'Labeling Review', 'Biocompatibility Testing'). Include timeline view for submission milestones and kanban view for tracking regulatory stages."

**AGENT BLUEPRINT:** *Trigger:* New device entry or FDA guidance update. *Actions:* Research predicate devices, analyze regulatory pathway options, generate submission timeline, update compliance requirements, notify regulatory team of pathway recommendations, escalate if high-risk classification identified.

### 2. Clinical Trial Protocol Orchestration Agent

**Relevance:** High - 73% of medical devices require clinical evidence
**Value Driver:** Scale Without Overhead
**The Pain:** Clinical research coordinators juggle multiple study protocols, IRB submissions, patient recruitment timelines, and regulatory reporting requirements. Protocol deviations and enrollment delays are tracked manually across spreadsheets.
**The Solution:** AI agent manages end-to-end clinical trial operations: auto-generates IRB submissions, tracks patient recruitment against enrollment targets, monitors protocol adherence, and coordinates with clinical sites.
**The Outcome:** Reduce clinical trial startup time by 40%, improve protocol compliance by 60%, eliminate manual tracking overhead.
**Discovery Questions:**
- How many clinical studies are you running concurrently?
- What's your average time from protocol approval to first patient enrolled?
- How do you currently track protocol deviations and adverse events?
- What percentage of your studies meet original enrollment timelines?

**Industry Context:** Good Clinical Practice (GCP) requirements and 21 CFR Part 820 compliance demand meticulous documentation and real-time monitoring across multiple clinical sites.

**VIBE PROMPT:** "Build a clinical trial management system with Study Name (text), Protocol Number (text), Principal Investigator (person), IRB Status (status: Pending/Approved/Modifications Required), Patient Enrollment Target (numbers), Current Enrollment (numbers), Clinical Sites (multiple select), Adverse Events (long text), Protocol Deviations (checklist), Study Timeline (timeline with milestones for screening, enrollment, follow-up), and Regulatory Reporting (files). Add dashboard view for enrollment metrics and calendar view for study visits."

**AGENT BLUEPRINT:** *Trigger:* Weekly enrollment review, adverse event report, protocol deviation entry. *Actions:* Compare enrollment to targets, generate recruitment alerts, prepare regulatory reports, coordinate site communications, escalate enrollment delays to clinical ops team.

### 3. Medical Device Design Control Compliance Agent (WOW MOMENT)

**Relevance:** Critical - FDA requires design controls for Class II/III devices
**Value Driver:** Replace/Augment Headcount + Consolidate Tech Stack
**The Pain:** Design control documentation (21 CFR Part 820.30) requires maintaining design history files, verification/validation protocols, and traceability matrices across engineering teams. Manual compliance tracking creates bottlenecks and FDA audit risks.
**The Solution:** AI agent automatically maintains design history files, tracks verification/validation status, ensures design transfer completeness, and generates audit-ready documentation packages. Proactively identifies compliance gaps before FDA inspections.
**The Outcome:** Achieve 100% design control compliance, eliminate manual DHF maintenance, reduce FDA inspection preparation from weeks to hours.
**Discovery Questions:**
- How do you currently maintain design history files for your medical devices?
- What's your process for design verification and validation documentation?
- How long does FDA inspection preparation typically take your team?
- Have you experienced FDA 483 observations related to design controls?

**Industry Context:** FDA's Quality System Regulation (QSR) mandates comprehensive design control documentation for most medical devices, with non-compliance resulting in significant regulatory delays.

**VIBE PROMPT:** "Create a design control management system with Device Project (text), Design Requirements (long text), Design Specifications (files), Verification Protocols (checklist with items like 'Performance Testing', 'Biocompatibility', 'Software Validation'), Validation Studies (files), Design Review Status (status: Planned/In Progress/Complete), Risk Analysis (files with FMEA documents), Design Transfer (checklist), and Audit Trail (audit log). Include gantt view for design control timeline and form view for design review meetings."

**AGENT BLUEPRINT:** *Trigger:* Design milestone completion, document upload, design change request. *Actions:* Update design history file, verify documentation completeness, cross-reference requirements traceability, generate compliance gap report, schedule design reviews, notify quality assurance of non-conformances.

### 4. Competitive Intelligence & Patent Landscape Agent

**Relevance:** High - Critical for IP strategy and market positioning
**Value Driver:** Replace/Augment Headcount
**The Pain:** Patent analysts manually search USPTO databases, monitor competitor product launches, and track licensing opportunities. Market intelligence gathering is time-intensive and often outdated by the time it reaches decision-makers.
**The Solution:** AI agent continuously monitors patent filings, analyzes competitor R&D pipelines, tracks medical device approvals, and provides automated competitive intelligence reports with IP landscape analysis.
**The Outcome:** Real-time competitive awareness, identify white space opportunities 6 months faster, reduce patent analyst workload by 70%.
**Discovery Questions:**
- How do you currently monitor competitor medical device patents and approvals?
- What's your process for identifying potential IP infringement risks?
- How often do you receive competitive intelligence updates?
- What percentage of your R&D resources are dedicated to patent landscape analysis?

**Industry Context:** Medical device innovation requires constant awareness of patent landscapes, especially with increasing numbers of digital health patents and complex cross-licensing agreements.

**VIBE PROMPT:** "Build a competitive intelligence system with Competitor Name (text), Device Category (dropdown: Cardiovascular/Orthopedic/Neurology/Digital Health), Patent Applications (numbers), Recent FDA Approvals (text), Technology Focus (tags), IP Risk Assessment (status: Low/Medium/High), Market Impact (rating 1-5), Patent Expiration Dates (date), and Licensing Opportunities (long text). Include timeline view for patent expirations and kanban view for competitive threat analysis."

**AGENT BLUEPRINT:** *Trigger:* New patent filing detected, competitor FDA approval, quarterly intelligence review. *Actions:* Analyze patent claims relevance, assess IP infringement risk, generate competitive summary report, identify licensing opportunities, alert legal team of high-risk patents.

### 5. Translational Research Pipeline Agent

**Relevance:** High - Bridges basic research to clinical applications
**Value Driver:** Scale Without Overhead
**The Pain:** Translational research teams struggle to prioritize promising discoveries, track technology readiness levels, and coordinate between basic research and clinical development. Innovation pipeline decisions are made with incomplete data visibility.
**The Solution:** AI agent evaluates research proposals against clinical needs, tracks technology maturation milestones, prioritizes translational opportunities, and coordinates cross-functional research teams.
**The Outcome:** 2x faster translation from bench to bedside, improve innovation portfolio ROI by 45%, eliminate research silos.
**Discovery Questions:**
- How do you currently evaluate which basic research findings to pursue for clinical development?
- What's your process for tracking technology readiness levels across your pipeline?
- How do you coordinate between basic research scientists and clinical development teams?
- What percentage of your translational research projects successfully reach clinical trials?

**Industry Context:** Translational medicine requires coordinating between academic research partnerships, NIH/NSF grant requirements, and commercial development timelines.

**VIBE PROMPT:** "Create a translational research pipeline with Research Project (text), Principal Investigator (person), Technology Readiness Level (dropdown: TRL 1-9), Clinical Application (text), Market Potential (rating 1-5), Funding Source (multiple select: NIH/NSF/Internal/Industry Partner), Patent Status (status: Filed/Pending/Granted), Regulatory Path (text), Commercialization Timeline (timeline), and Success Metrics (numbers). Add portfolio view for TRL tracking and priority matrix for investment decisions."

**AGENT BLUEPRINT:** *Trigger:* Quarterly pipeline review, research milestone completion, funding opportunity. *Actions:* Evaluate clinical relevance score, update TRL assessment, identify commercialization barriers, coordinate stakeholder reviews, recommend go/no-go decisions, alert business development of partnership opportunities.

### 6. Post-Market Surveillance & Quality Intelligence Agent

**Relevance:** Critical - FDA requires post-market monitoring for most devices
**Value Driver:** Replace/Augment Headcount + Consolidate Tech Stack
**The Pain:** Quality teams manually process medical device reports (MDRs), track customer complaints, and monitor field corrective actions. Post-market surveillance data is fragmented across multiple systems, creating regulatory compliance risks.
**The Solution:** AI agent aggregates post-market data, automatically generates MDR submissions, analyzes complaint trends, and proactively identifies potential safety signals requiring corrective action.
**The Outcome:** 100% MDR compliance, identify safety trends 3x faster, reduce quality investigation time by 50%.
**Discovery Questions:**
- How do you currently collect and analyze post-market surveillance data?
- What's your average time to investigate and resolve customer complaints?
- How many MDR submissions do you file annually?
- Have you had FDA enforcement actions related to post-market surveillance?

**Industry Context:** FDA's Unique Device Identification (UDI) requirements and Medical Device User Fee Act mandate comprehensive post-market surveillance for device safety.

**VIBE PROMPT:** "Build a post-market surveillance system with Device Model (text), UDI Number (text), Customer Complaints (long text), MDR Status (status: Reported/Under Investigation/Closed), Severity Assessment (dropdown: Death/Serious Injury/Malfunction), Root Cause Analysis (files), Corrective Actions (checklist), FDA Communications (files), and Trend Analysis (charts). Include dashboard view for complaint metrics and calendar view for MDR submission deadlines."

**AGENT BLUEPRINT:** *Trigger:* Customer complaint received, quality threshold exceeded, MDR submission due. *Actions:* Assess reportability criteria, generate MDR draft, coordinate investigation team, analyze complaint trends, recommend corrective actions, notify regulatory affairs of significant events.

## Industry Terminology

| Term | Definition | Context |
|------|------------|---------|
| **510(k) Premarket Notification** | FDA submission demonstrating device equivalence to predicate | Most common regulatory pathway for Class II medical devices |
| **Design History File (DHF)** | Complete record of design control activities per 21 CFR Part 820.30 | Required documentation for FDA inspections |
| **Institutional Review Board (IRB)** | Ethics committee reviewing clinical research protocols | Required approval for human subjects research |
| **Medical Device Report (MDR)** | FDA-required adverse event reporting for marketed devices | Mandatory post-market surveillance requirement |
| **Technology Readiness Level (TRL)** | Scale 1-9 measuring technology maturation from concept to deployment | Used to evaluate translational research progress |
| **Unique Device Identifier (UDI)** | FDA-mandated unique numeric identifier for medical devices | Required for device tracking and post-market surveillance |
| **Good Clinical Practice (GCP)** | International quality standards for clinical trial conduct | Ensures clinical data integrity and patient safety |
| **Quality System Regulation (QSR)** | FDA's comprehensive quality requirements for medical device manufacturing | Covers design controls, production, and quality assurance |
| **De Novo Pathway** | FDA classification process for novel medical devices without predicates | Alternative regulatory route for breakthrough technologies |
| **Breakthrough Device Designation** | FDA program expediting review of innovative medical devices | Priority review for devices addressing unmet medical needs |

## Typical Stakeholder Roles

| Role | Responsibilities | Key Pain Points | monday.com Value |
|------|------------------|-----------------|------------------|
| **VP of Product Development** | Strategic R&D portfolio management, resource allocation | Balancing innovation speed with regulatory compliance | Executive dashboard for pipeline visibility and resource optimization |
| **Regulatory Affairs Director** | FDA submissions, compliance strategy, regulatory intelligence | Manual tracking of complex regulatory requirements | Automated compliance monitoring and submission preparation |
| **Clinical Research Manager** | Clinical study oversight, protocol management, site coordination | Multi-study coordination and enrollment tracking | Centralized clinical operations with automated reporting |
| **Quality Assurance Manager** | Design controls, post-market surveillance, audit preparation | Manual documentation maintenance and compliance tracking | Automated quality system with audit-ready documentation |
| **Biomedical Engineer** | Device design, verification/validation, technical documentation | Design control compliance and cross-functional coordination | Integrated design management with automated traceability |
| **IP/Patent Counsel** | Patent strategy, competitive intelligence, licensing | Manual patent landscape monitoring and analysis | AI-powered competitive intelligence and IP risk assessment |
| **Clinical Affairs Specialist** | IRB submissions, clinical site management, protocol compliance | Multi-site coordination and regulatory reporting | Streamlined clinical operations with compliance automation |
| **Translational Research Scientist** | Technology development, clinical application assessment | Prioritizing research opportunities and tracking maturation | Portfolio management with TRL tracking and ROI analysis |

## Adjacent Departments

| Department | Collaboration Points | Integration Opportunities |
|------------|---------------------|--------------------------|
| **Clinical Operations** | Clinical trial execution, patient recruitment, data collection | Shared clinical trial management and regulatory reporting |
| **Quality & Regulatory** | Design control compliance, FDA submissions, post-market surveillance | Unified quality management system with regulatory workflows |
| **Business Development** | Technology licensing, partnership evaluation, market analysis | Competitive intelligence integration with deal flow management |
| **Legal/IP** | Patent filing, IP strategy, licensing agreements | Patent landscape monitoring with legal workflow integration |
| **Manufacturing** | Design transfer, production scale-up, quality control | Design control handoff with manufacturing execution integration |
| **Marketing** | Market research, competitive analysis, product positioning | Competitive intelligence sharing with marketing campaign planning |
| **Information Technology** | Digital health platforms, cybersecurity, data infrastructure | IT project management integration with medical device development |
| **Finance** | R&D budgeting, project ROI analysis, investment prioritization | Financial tracking integration with R&D portfolio management |

## Competitive Landscape

| Competitor | Strengths | Weaknesses | monday.com Advantage |
|------------|-----------|------------|---------------------|
| **Veeva Vault QualityDocs** | Established in life sciences, regulatory expertise | Expensive, complex implementation, limited customization | AI-first approach, lower TCO, rapid deployment with Vibe |
| **Ennov Document Management** | GxP compliance, validation services | Legacy interface, limited automation, high maintenance | Modern UI, intelligent automation, scalable platform |
| **IQVIA Clinical Platform** | Clinical trial expertise, global reach | Focus on pharma over devices, expensive licensing | Medical device specialization, integrated approach, cost-effective |
| **Sparta TrackWise** | Quality management maturity, FDA validation | Outdated technology, slow innovation, complex workflows | AI agents, intuitive design, continuous innovation |
| **Greenlight Guru** | Medical device focus, design control specialty | Limited AI capabilities, single-purpose solution | Comprehensive AI platform, multi-department integration |
| **Custom/Legacy Solutions** | Tailored to specific needs, existing integrations | High maintenance costs, limited scalability, no AI | Out-of-the-box AI capabilities, lower maintenance, future-ready platform |

## Objection Handling

| Objection | Response Strategy | Supporting Points |
|-----------|------------------|-------------------|
| **"We need FDA-validated systems"** | monday.com provides comprehensive validation support and GxP compliance documentation | Our enterprise customers include regulated industries; we offer 21 CFR Part 11 compliance and validation services |
| **"Our regulatory requirements are too complex"** | Vibe enables rapid customization for any regulatory framework without custom development | Built for adaptability; customers configure complex workflows in minutes, not months |
| **"AI isn't proven in medical device development"** | Position as "coming soon" innovation advantage; current AI features (Sidekick) provide immediate value | Early adopters gain competitive advantage; current automation capabilities already reduce manual work significantly |
| **"Integration with existing clinical systems"** | monday.com integrates with 200+ applications including CTMS, EDC, and regulatory systems | Native integrations plus robust API; customers consolidate tools rather than add complexity |
| **"Cost compared to specialized solutions"** | Total cost of ownership analysis: eliminate multiple point solutions with unified platform | One platform replaces 3-5 specialized tools; ROI through headcount optimization and faster time-to-market |
| **"Change management and user adoption"** | Intuitive interface requires minimal training; gradual rollout minimizes disruption | 92% user adoption rate; customers report faster onboarding than legacy alternatives |
| **"Data security and compliance concerns"** | Enterprise-grade security with SOC 2 Type II, ISO 27001, HIPAA compliance | Multiple compliance certifications; customers include Fortune 500 healthcare organizations |
| **"We need local deployment/data residency"** | Discuss private cloud and data residency options for compliance requirements | Flexible deployment models available; work with IT teams on specific requirements |

## Proof Points

*[Placeholder for customer success stories, case studies, and quantified outcomes specific to Medical & Surgical Hospitals' Product & R&D departments. To be populated with real customer data and testimonials.]*

---

*Generated: 2026-02-20 | Version: 2.0 (with Vibe Prompts + Agent Blueprints)*